News

September 6, 2019
Orchestra BioMed™, Inc., a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine, announced that it has received CE Mark approval for its Moderato® implantable pulse generator system that delivers BackBeat Cardiac Neuromodulation Therapy™ (CNT) for treatment of hyp
September 6, 2019
Bardy Diagnostics, Inc., a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced it received 510(k) clearance from the U.S.
September 4, 2019
AtriCure, Inc., a leading innovator in surgical treatment for atrial fibrillation (Afib) and left atrial appendage (LAA) management, announced that it has received U.S.
September 4, 2019
Paris, France – 3 Sept 2019: Edoxaban in combination with a P2Y12 inhibitor is noninferior to standard triple therapy for preventing bleeding in patients with atrial fibrillation after coronary stenting.
September 3, 2019
Paris, France – 3 Sept 2019: Implantable cardioverter-defibrillator (ICD) use is associated with reduced short- and long-term mortality in patients with heart failure, according to late breaking research presented in a Hot Line Session today at ESC Congress 2019
September 3, 2019
The European Society of Cardiology (ESC) Guidelines on supraventricular tachycardia were published online in European Heart Journal,(1) and on the ESC website.(2) The document highlights how catheter ablation is revolutionizing care for this group of common arrhythmias.
September 3, 2019
Results from The Atrial Fibrillation Progression Trial (ATTEST), were presented at the ESC* Congress 2019 in Paris, France. ATTEST is the first randomized controlled trial to directly compare the effectiveness of ablation using radiofrequency (RF) catheters versus standard antiarrhythmic drugs (AAD) in delaying atrial fibrillation (AF) progression.
August 19, 2019
Bardy Diagnostics, Inc., a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that Informa Pharma Intelligence, a leading international healthca